Importantly, it has already been demonstrated that total ADA (tADA) and its isoenzymes ADA1 and ADA2 can be measured accurately in saliva samples, even after the chemical inactivation of SARS-CoV-2, and that their levels are significantly increased in saliva of COVID-19 patients compared to healthy controls (Franco-Martínez et al., 2021b). The gene discussed is ADA; the disease is COVID-19.